PERNUVI owner Contact Information online
from Teva Pharmaceutical Industries Limited
PERNUVI
US serial number:87207066
Application filling date:Oct. 18, 2016
Register:Principal
Mark type:Trademark
Status:Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Status date:Feb. 28, 2017
Publication date:Jan. 03, 2017
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations for the treatment of neurological diseases
respiratory diseases
cancer and pain
Current owner owner name:Teva Pharmaceutical Industries Limited
Current owner owner address:Science Based Industries Campus
Har Hotzvim, P.O. Box 1142
Jerusalem
ISRAEL
91010
Current owner legal entity type:limited company (ltd.)
Current owner state or country:ISRAEL
Correspondent name address:HERSCHEL PEREL
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET ROAD
TRADEMARKS DEPARTMENT
HORSHAM,
PENNSYLVANIA
UNITED STATES
19044
Correspondent phone:215-293-6406
Correspondent email:herschel.perel@tevapharm.com
shelby.barilone@tevapharm.com
Correspondent fax:215-293-7200
Correspondent email authorized:Yes
Trademark staff tm attorney:WATTS-FITZGERALD, CAIT
Trademark staff law office assigned PERNUVI:LAW OFFICE 111
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
